Jean-Paul Leon

Director/Board Member at Biocortech SAS

Health Technology

Profile

Jean-Paul Leon is a Director of Biocortech SAS.
Previously, he was Chief Financial Officer and Executive Vice President of Corporate Strategy for Sanofi.
Mr. Leon has experience in the pharma environment.

Jean-Paul Leon active positions

Companies	Position	Start
Biocortech SAS Biocortech SAS Pharmaceuticals: MajorHealth Technology Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France.	Director/Board Member	-

All active positions of Jean-Paul Leon

Former positions of Jean-Paul Leon

Companies	Position	End
Sanofi-Aventis U.S. LLC Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ.	Director of Finance/CFO	-

See the detail of Jean-Paul Leon's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jean-Paul Leon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Biocortech SAS Biocortech SAS Pharmaceuticals: MajorHealth Technology Biocortech SAS discovers and develops drug therapies for brain disorders. The company is engaged in treating pathologies and focuses its R&D program on depression, schizophrenia and cognitive deficits. Biocortech develops pharmaceuticals for deficient pathways in the adult brain or deficient receptors via the modulation of RNA editing mechanisms. The company was founded by Dinah Weissmann in 2001 and is headquartered in Paris, France.	Health Technology
Sanofi-Aventis U.S. LLC Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ.	Health Technology